Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Ra Capital Management, L.P. reported a 37.90% stake in Artiva Biotherapeutics, Inc. (Schedule 13D/A)
Event Jul 22, 2026 · Filed Jul 23, 2026
Ra Capital Management, L.P. reported a 37.90% stake in Artiva Biotherapeutics, Inc., 18,415,956 shares, with active intent on Jul 22, 2026. Filed Jul 23, 2026 (Schedule 13D/A).
- Stake
- 37.90%
- Shares
- 18,415,956
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 37.90% | 18,415,956 |
| Peter Kolchinsky | 37.90% | 18,415,956 |
| Rajeev Shah | 37.90% | 18,415,956 |
| RA Capital Healthcare Fund, L.P. | 35.50% | 17,242,483 |
Source
Related
- Artiva Biotherapeutics, Inc.
- Ra Capital Management, L.P.
- Artiva Biotherapeutics, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 15, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · May 13, 2026
- Form 4 · Aslan Fred · Oct 7, 2026
- Form 4 · Aslan Fred · Oct 6, 2026
- Form 4 · Banerjee Subhashis · Oct 6, 2026
- Form 4 · Bush Jennifer · Oct 6, 2026
- Form 4 · Horan Christopher · Oct 6, 2026